OpenAI just revealed what its new in-house team, OpenAI for Science, has been up to. The firm has released a free LLM-powered ...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in The Trade Desk Inc (Symbol: TTD), where a total of 69,953 contracts have traded so far, ...

Justin Gaethje rolled back the years to beat Paddy Pimblett and claim the interim UFC lightweight title as the flagship ...

Koi security researchers found that when NPM installs a dependency from a Git repository, configuration files such as a ...

Unlike regular search engines, AI browsers suffer from algorithmic inconsistency due to their black-box nature — and even ...

Replit is racing to turn its AI coding tools into a full-stack software factory, and investors appear ready to bankroll that ambition at massive scale. The company is seeking a fresh $400 million ...

The Republican Party of India (Athawale) chief and Union Minister Ramdas Athawale on Tuesday said his party was excluded from the seat-sharing talks between the BJP and the Eknath Shinde-led Shiv Sena ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...